About Us

  • Home
  • /
  • About
  • /
  • History
  • 2014

    Inspection of manufacturing plant and approval of GMP by DIGEMID (Dirección General de Medicamentos, Insumos y Drogas), Peru

    Inspection of manufacturing plant, approval of GMP and gaining of export approval from Ethiopian Food and Drug Administration (EFDA), Ethiopia

    Export approval from National Drug Authority (NDA), Uganda

  • 2015

    Acquiring of Export Approval from the National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria.

    Conduction of ISO (9001:2008) Surveillance Audit.

    Pharma Technical (PT) Good Manufacturing Practice (GMP) Audit by Roche.

  • 2016

    Recipient of ISO 9001:2008 Quality Standard certified by Orion Registrar Inc., USA.

    Inspection of manufacturing plant by Medicines Control Authority of Zimbabwe

    Approval of GMP Compliance, Pharmacy and Poisons Board, Kenya.

  • 2017

    Conduction of ISO (9001:2008) Surveillance Audit.

    Recipient of ISO (9001:2008) Certification.

    Renewal of Biological & Non-biological product manufacturing license.

  • 2018

    Compliance with cGMP according to the Compendium of guidelines and related materials.

    Site transfer from Novartis (Bangladesh) Ltd. to Klarris Pharmaceuticals Ltd.

    Pharma Technical (PT) Good Manufacturing Practice (GMP) Audit by Roche.

  • 2019

    Formation of Klarris Pharmaceuticals Ltd.

    Licensee agreement with F. Hoffmann-La Roche Limited, Switzerland.

    Renewal of Biological & Non-biological product manufacturing license.

keyboard_arrow_up